Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Other Non-Current Liabilities (2022 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $2.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 4.42% to $2.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.6 million, a 4.42% decrease, with the full-year FY2024 number at $2.8 million, changed N/A from a year prior.
  • Other Non-Current Liabilities was $2.6 million for Q3 2025 at Werewolf Therapeutics, down from $2.6 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.8 million in Q2 2024 to a low of $191000.0 in Q2 2022.
  • A 3-year average of $1.9 million and a median of $2.6 million in 2025 define the central range for Other Non-Current Liabilities.
  • Biggest YoY gain for Other Non-Current Liabilities was 4.42% in 2025; the steepest drop was 7.11% in 2025.
  • Werewolf Therapeutics' Other Non-Current Liabilities stood at $191000.0 in 2022, then surged by 1381.15% to $2.8 million in 2024, then decreased by 7.6% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for HOWL's Other Non-Current Liabilities are $2.6 million (Q3 2025), $2.6 million (Q2 2025), and $2.7 million (Q1 2025).